Japan’s MHLW approves Breyanzi, a new CAR T cell therapy for the treatment of patients with relapsed or refractory large B-cell lymphoma and follicular lymphoma.- BMS KK
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest